Background Transoral robotic surgery (TORS) has been used in the salvage setting for head
and neck cancers both with and without reconstruction. The complications of salvage TORS …

Robotics applications in facial plastic surgery has been practical and observed to have
benefits. For instance, minimal invasiveness, small number of incisions, less blood loss …

Background Recurrent head and neck squamous cell carcinomas (HNSCC) are frequently
managed with salvage surgery, but the impact these operations have on function and quality …

Background Transoral robotic surgery (TORS) is an emerging minimally invasive surgical
treatment for residual, recurrent, and new primary head and neck cancers in previously …

Background Transoral robotic surgery (TORS) is increasingly employed in the management
of oropharyngeal cancer without adjuvant treatment. Attaining safe surgical margins is …

Locoregional recurrent thyroid cancer is commonly treated with re-do operation. This study
aimed to investigate the feasibility of using robotic system for re-do operation in locoregional …

Nonsurgical primary treatment of early and advanced laryngeal squamous cell carcinoma,
employing radiotherapy with or without chemotherapy, is considered a standard of care in …

Purpose: The incidence of oropharyngeal squamous cell carcinoma (OPSCC) has
continually increased during the past several decades. Using transoral robotic surgery …

Simple Summary Transoral robotic surgery (TORS) with spontaneous healing is associated
with improved quality of life as compared to traditional open surgery in small pharyngeal …

Objective Transoral robotic surgery (TORS) has evolved since its 2009 US Food and Drug
Administration approval for use in local stage T1–T2 oropharyngeal carcinoma. The ability to …